ArticleAmerican journal of human genetics2021

A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer.

Ashley Jermusyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.